LAM IPM WOUND GEL (TM) GRANTS DISTRIBUTION RIGHTS FOR BRAZIL AND ARGENTINA

LAM Pharmaceutical, Corp. (OTC BB: LAMP; Frankfurt: LAM; Berlin: LAM), a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced today that it granted its Latin American distribution partner, aQva Pharmaceuticals, exclusive distribution rights for Brazil and Argentina.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/10-12-2005/0004166275&EDATE=)